Nope, can't request a meeting with FDA to review a submission until the submission is made so FDA has time to review before meeting. And who on this forum said, in face of much ridicule to the contrary, that the July 6 update didn't at all say there was meeting the following week, only a statement declaring an anticipated submission to be done the following week with further anticipation of reviewing the submission at a meeting, date unspecified?
And what's this revised wording to "week of July 14" mean? July 14 was a Friday. Per original July 6 update, they anticipated submission week of July 10. So guess it wasn't submitted until week of July 17?
Don't feel bad. I'm a technical reader/writer and easily pick up on those details. Most people are casual readers and there's nothing wrong with that. Even RDGL's Twitter flunky misread his boss' July 6 update.
Market Data 
Markets 
AI
